Septerna, Inc. SEPN
We take great care to ensure that the data presented and summarized in this overview for Septerna, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in SEPN
Top Purchases
Top Sells
About SEPN
Insider Transactions at SEPN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2025
|
Daniel D. Long SVP, Drug Discovery |
SELL
Open market or private sale
|
Direct |
3,501
-3.63%
|
$63,018
$18.06 P/Share
|
|
Aug 18
2025
|
Uwe Klein SVP, Biological Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
23,008
+33.06%
|
$92,032
$4.11 P/Share
|
|
Apr 03
2025
|
Jeffrey Finer Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.6%
|
$10,000
$2.76 P/Share
|
|
Apr 02
2025
|
Jeffrey Finer Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+5.73%
|
$100,000
$2.76 P/Share
|
|
Mar 07
2025
|
Alan Ezekowitz |
BUY
Open market or private purchase
|
Direct |
13,319
+10.19%
|
$79,914
$6.93 P/Share
|
|
Mar 06
2025
|
Alan Ezekowitz |
BUY
Open market or private purchase
|
Direct |
41,355
+28.43%
|
$248,130
$6.0 P/Share
|
|
Mar 05
2025
|
Alan Ezekowitz |
BUY
Open market or private purchase
|
Direct |
37,835
+37.62%
|
$189,175
$5.82 P/Share
|
|
Mar 04
2025
|
Alan Ezekowitz |
BUY
Open market or private purchase
|
Direct |
7,491
+23.12%
|
$44,946
$6.35 P/Share
|
|
Feb 27
2025
|
Gil M Labrucherie Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
3,718
+8.5%
|
$18,590
$5.85 P/Share
|
|
Feb 27
2025
|
Jeffrey Finer Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+0.39%
|
$15,000
$5.8 P/Share
|
|
Feb 26
2025
|
Jeffrey Finer Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+0.52%
|
$20,000
$5.7 P/Share
|
|
Feb 25
2025
|
Gil M Labrucherie Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
6,282
+14.76%
|
$31,410
$5.59 P/Share
|
|
Feb 25
2025
|
Jeffrey Finer Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+1.29%
|
$50,000
$5.68 P/Share
|
|
Feb 24
2025
|
Third Rock Ventures Vi, L.P. |
BUY
Open market or private purchase
|
Direct |
18,861
+0.45%
|
$113,166
$6.0 P/Share
|
|
Feb 21
2025
|
Third Rock Ventures Vi, L.P. |
BUY
Open market or private purchase
|
Direct |
427,668
+9.26%
|
$2,138,340
$5.94 P/Share
|
|
Feb 21
2025
|
Gil M Labrucherie Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
5,000
+14.29%
|
$25,000
$5.85 P/Share
|
|
Feb 20
2025
|
Third Rock Ventures Vi, L.P. |
BUY
Open market or private purchase
|
Direct |
612,674
+14.0%
|
$3,063,370
$5.92 P/Share
|
|
Feb 20
2025
|
Gil M Labrucherie Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
14,500
+36.71%
|
$72,500
$5.88 P/Share
|
|
Feb 19
2025
|
Gil M Labrucherie Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
10,500
+50.0%
|
$52,500
$5.51 P/Share
|
|
Oct 28
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
4,170,000
+29.89%
|
$75,060,000
$18.0 P/Share
|
Last 12 Months Summary
Buy / Acquisition
1.29M
Shares
From
6
Insiders
| Open market or private purchase | 1.22M shares |
|---|---|
| Exercise of conversion of derivative security | 78K shares |
Sell / Disposition
3.5K
Shares
From
1
Insiders
| Open market or private sale | 3.5K shares |
|---|